Navigating Inflation and Workforce Shifts: Advancing Clinical Site Budgeting Strategies
Webinar Date/Time: Thursday, October 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Join IQVIA Technologies to discuss developing fair market value (FMV) for investigator grants and budgeting for clinical trials in today's tumultuous environment.
Register Free: https://www.appliedclinicaltrialsonline.com/act/budgeting-strategies
Event overview
While inflation has slowed after reaching a four-decade high last summer, prices remain high. Additionally, attrition rates at clinical research sites still exceed those of most other industries. Taken together, these two market conditions make developing fair marketing value (FMV) for investigator grants a challenging process. Join IQVIA Technologies for a topical discussion on budgeting in today’s tumultuous environment.
Three key take-aways
- Understand the purpose of a FMV benchmarking tool and how budget data is transformed and conveyed.
- Learn about the relationship between exchange rates and inflation and discuss methods to mitigate volatility.
- Review a comprehensive, holistic approach that incorporates specialized inflation analysis.
Speaker:
Jesse Glass
Data Science Manager, GrantPlan Development
IQVIA Technologies
Jesse Glass received his PhD in Machine Learning from Temple University in 2020 and his undergraduate degree in Economics from Tulane University in 2008. His work is focused on integrating Probabilistic Models for improved data quality control to present data with a richer tapestry. His work also includes incorporating text processing to streamline user experience and advanced modeling capabilities.
Register Free: https://www.appliedclinicaltrialsonline.com/act/budgeting-strategies
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
